Highest-scoring questions on the site.
Details up front: injection-site erythema · five · oral semaglutide. I would like to understand the steps well enough to explain them to someone else. I have access…
Concretely: QST · tirzepatide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
The particulars: liraglutide · 99.1%. I would rather understand the derivation than memorise the outcome. Two people I asked gave two answers that differ by a factor…
Details up front: KP · FGP · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
The specifics, since they change the answer: a sterility test · retatrutide. I want to know what the trade-off actually is rather than which option is fashionable. I…
Numbers first: mazdutide · 10 mg/mL. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I would rather…
What I have: TFC · tirzepatide. I have two candidate explanations and no way to distinguish them. The same procedure has worked without incident several times…
Numbers first: racemisation · orforglipron · minus 20 °C. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Setup, so nobody has to ask: Medutest · Nantong Guangyuan Chemical. I would like help reading this properly rather than being told what conclusion to reach. I have…
Numbers first: racemisation · orforglipron · minus 80 °C. I can predict the outcome but I cannot explain it, which means I will get the next case wrong. I would like…
I understand in general terms that peptides do not survive oral administration - stomach acid, proteases, and a wall of epithelium that evolved specifically to keep…
What I am working with: ERP · SGN · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
Twelve weeks in, losing roughly 1.1 kg a week, and my fasting LDL-C has gone from 2.7 to 3.3 mmol/L. Total cholesterol up from 4.6 to 5.2. Triglycerides down from 1.9…
Concretely: survodutide · 5 mg/mL · three weeks. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
What I have: a GLP-1 receptor agonist · 4 mg/mL · two weeks. I am asking for verification rather than opinion, ideally with something I can read myself. It is…
Baseline ALT was 24 U/L. Fourteen weeks into semaglutide it came back at 41 U/L, still inside the lab's quoted range of 0 to 50 but a 71% rise from where I started. I…
The case in front of me: HJ · tirzepatide. The claim is plausible, which is exactly why I want to check it. I am able to read a paper if someone points me at one. Can…
Conditions: 2.5 mg · 0.5 mL. I want the working, not the result — I need to be able to redo it with different numbers. I care about the precision as well as the value…
A private clinic offered me a "pre-treatment endocrine screen" including serum calcitonin, with the reasoning that the boxed warning concerns C cells and calcitonin…
I am asking mechanistically rather than practically — I want the model, not the protocol. This is presented as though it settles something, and I am not convinced it…
Timing, since it always gets asked: this started nine days after a dose step. I want to understand what this actually establishes, as opposed to what it is being used…
Stated plainly: an endotoxin test · a GLP-1 receptor agonist. I would like to set this up properly once, rather than adjust it repeatedly. My budget is real but not…
What I am working with: SOUL · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the source. I…
Two related mechanism questions I have never seen answered together. First, how much of the weight loss is attributable to delayed gastric emptying as opposed to…